|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 417/14 | (2006.01) |
| C07D 417/14 | (2013.01) | ||
| A61K 31/501 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3383873 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16806028.3 |
| Date of filing the European patent application | 2016-11-30 | |
| (97) | Date of publication of the European application | 2018-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/079250 |
| Date | 2016-11-30 |
| (87) | Number | WO 2017/093299 |
| Date | 2017-06-08 |
| (30) | Number | Date | Country code |
| 201562260789 P | 2015-11-30 | US |
| (72) |
FINLAY, Maurice, Raymond, Verschoyle , GB
NISSINK, Johannes, Wilhelmus, Maria , GB
CHARLES, Mark, David , GB
|
| (73) |
Cancer Research Technology Limited ,
2 Redman Place, London E20 1JQ,
GB
|
| (54) | 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER |
| 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER |